Valuation: Getinge AB

Market Cap 6.46TCr 681.12Cr 589.17Cr 550.2Cr 504.72Cr 949.32Cr 65TCr 964.4Cr 2.53TCr 32TCr 2.56TCr 2.5TCr 1,07400Cr P/E 2026 *
20.9x
P/E 2027 * 18.6x
Enterprise Value 7.31TCr 771.45Cr 667.3Cr 623.16Cr 571.66Cr 1.08TCr 73TCr 1.09TCr 2.87TCr 37TCr 2.9TCr 2.83TCr 1,21700Cr EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.91x
Free-Float
78.61%
Yield 2026 *
2.19%
Yield 2027 * 2.38%
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-.--% - - 681.12Cr
-0.06%+1.08%+35.00%+30.97% 1.28TCr
-0.29%-0.17%+19.85%+23.70% 681.12Cr
+0.79%+2.67%+50.66%+29.03% 620.65Cr
+6.41%+8.59% - - 550.45Cr
-0.58%-8.31%-27.67%+32.66% 436.01Cr
+1.30%-2.64%-22.46%-18.51% 404.39Cr
+4.46%+10.44%+47.26%-40.70% 190.85Cr
-0.51%-5.18%-15.07%+195.36% 175.19Cr
+3.67%+6.92%+67.01%-8.07% 170.88Cr
Average +1.61%+1.76%+19.32%+30.55% 500.93Cr
Weighted average by Cap. +1.16%+1.40%+21.83%+26.68%

Financials

2026 *2027 *
Net sales 3.52TCr 371.03Cr 320.94Cr 299.71Cr 274.94Cr 517.13Cr 35TCr 525.34Cr 1.38TCr 18TCr 1.39TCr 1.36TCr 59TCr 3.71TCr 391.27Cr 338.44Cr 316.06Cr 289.94Cr 545.33Cr 37TCr 553.99Cr 1.46TCr 19TCr 1.47TCr 1.44TCr 62TCr
Net income 308.6Cr 33Cr 28Cr 26Cr 24Cr 45Cr 3.1TCr 46Cr 121.12Cr 1.55TCr 122.28Cr 119.6Cr 5.14TCr 345.72Cr 36Cr 32Cr 29Cr 27Cr 51Cr 3.47TCr 52Cr 135.69Cr 1.74TCr 136.98Cr 133.99Cr 5.75TCr
Net Debt 856.06Cr 90Cr 78Cr 73Cr 67Cr 125.9Cr 8.6TCr 127.9Cr 336Cr 4.31TCr 339.2Cr 331.77Cr 14TCr 632.82Cr 67Cr 58Cr 54Cr 49Cr 93Cr 6.35TCr 95Cr 248.38Cr 3.19TCr 250.74Cr 245.26Cr 11TCr
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-